Home LiteratureArticle Details
PMID: 2854655 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Histopathologic risk factors for breast cancer in women with benign breast disease.

Seminars in surgical oncology ·Vol. 4 ·No. 4 ·1988-00-00 ·Pages 213-7

Page DL, Dupont WD

Abstract

Mammary epithelial hyperplasia indicates an increased likelihood of carcinoma development as it does in other organs. Prospective studies have demonstrated that in the premammography era about 70% of women undergoing surgical biopsy had no increased risk of cancer and have little if any hyperplastic alteration. About 25% of women have well-developed hyperplastic changes and have a risk elevation, controlled for age, of 1.5-2 times that of the general population. Less than 5% of women have atypical hyperplasia demonstrating some histologic features of carcinoma in situ, which indicates a risk elevation of 4-5 times. This is about one half the risk associated with microscopic carcinoma in situ. Therapeutic implications of these premalignant lesions rest predominantly in their indication for the heightened intensity of subsequent breast cancer surveillance and screening.

MeSH Terms
Breast/pathology Breast Diseases/pathology Breast Neoplasms/etiology,pathology Carcinoma in Situ/pathology Carcinoma, Intraductal, Noninfiltrating/pathology Epithelium/pathology Female Humans Hyperplasia Risk Factors
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Page D L
Department of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
Dupont W D
Article Info
Journal
Seminars in surgical oncology
Abbr.
Semin Surg Oncol
ISSN
8756-0437
Published
1988-00-00
Pages
213-7
Language
English
Region
United States
NLM ID
8503713
Subset
IM
Grants
NCI NIH HHS · N01-CB-74098 · United States
NCI NIH HHS · R01 CA-28223 · United States
NCI NIH HHS · R01-CA31698 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com